Vertex Pharmaceuticals, Inc. (VRTX)
470.87
-7.05
(-1.48%)
USD |
NASDAQ |
Feb 09, 16:00
470.36
-0.51
(-0.11%)
After-Hours: 07:57
Vertex Pharmaceuticals Shareholders Equity (Quarterly) : 17.32B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.86B |
| Total Liabilities (Quarterly) | 7.544B |
| Debt to Equity Ratio | 0.1059 |
| Current Ratio | 2.362 |
| Net Debt Paydown Yield | -0.18% |